Please login to the form below

Not currently logged in
Email:
Password:

AVENIR GLOBAL appoints global healthcare lead

Mirandi Dini expands role at communications firm

Miranda Dini

Communications firm AVENIR GLOBAL has appointed Miranda Dini to global healthcare lead.

Dini has been leading the AXON business, part of the AVENIR network, in Europe since 2012. While at the specialist healthcare communications company, Dini oversaw a significant growth of the operations, and helped to establish AXON as a leading health consultancy in London.

In her expanded role as global healthcare lead, she will lead cross-firm initiatives and strengthen the global healthcare business across all AVENIR GLOBAL brands. Dini will continue to lead the AXON business in Europe as well.

The AVENIR GLOBAL brands include AXON, Cherry, Hanover, NATIONAL, Padilla and SHIFT.

“We work with healthcare clients in every one of our brands, providing a wide range of services, including insights, strategic planning, public relations, medical communications, clinical trial services, creative, branding and market access,” said Ralph Sutton, international managing partner, AVENIR GLOBAL.

“Miranda has a deep understanding of the expertise within our firm and a proven track record for driving growth and collaboration.  She is the ideal person to help orchestrate our network resources to deliver great results for our clients,” he added.

Article by
Lucy Parsons

27th February 2020

From: Marketing

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...